NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (AMEX:NBS), the first company to specialize in the collection, processing and storage of stem cells from healthy adults for personal use in times of critical medical need, announced today that it has filed a far-reaching patent application that initiates the process of safeguarding the Company’s proprietary procedures for collecting, storing and developing potential biotherapies from adult stem cells derived from a patient’s own body. The application encompasses several groundbreaking concepts that include next generation biomedical services such as bio-insurance and the formulation of designer stem cell-related therapies for healthy individuals interested in mitigating potential health conditions in the future.
